These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2118325)

  • 1. Differential susceptibility to DL-alpha-difluoromethylornithine in clinical isolates of Trypanosoma brucei rhodesiense.
    Bacchi CJ; Nathan HC; Livingston T; Valladares G; Saric M; Sayer PD; Njogu AR; Clarkson AB
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1183-8. PubMed ID: 2118325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate lack of susceptibility of Ugandan Trypanosoma brucei rhodesiense to DL-alpha-difluoromethylornithine (DFMO).
    Iten M; Matovu E; Brun R; Kaminsky R
    Trop Med Parasitol; 1995 Sep; 46(3):190-4. PubMed ID: 8533023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to DL-alpha-difluoromethylornithine by clinical isolates of Trypanosoma brucei rhodesiense. Role of S-adenosylmethionine.
    Bacchi CJ; Garofalo J; Ciminelli M; Rattendi D; Goldberg B; McCann PP; Yarlett N
    Biochem Pharmacol; 1993 Aug; 46(3):471-81. PubMed ID: 8347171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination chemotherapy of drug-resistant Trypanosoma brucei rhodesiense infections in mice using DL-alpha-difluoromethylornithine and standard trypanocides.
    Bacchi CJ; Nathan HC; Yarlett N; Goldberg B; McCann PP; Sjoerdsma A; Saric M; Clarkson AB
    Antimicrob Agents Chemother; 1994 Mar; 38(3):563-9. PubMed ID: 8203855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in ornithine decarboxylase characteristics account for tolerance of Trypanosoma brucei rhodesiense to D,L-alpha-difluoromethylornithine.
    Iten M; Mett H; Evans A; Enyaru JC; Brun R; Kaminsky R
    Antimicrob Agents Chemother; 1997 Sep; 41(9):1922-5. PubMed ID: 9303385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trypanosoma brucei brucei: characterization of an ODC null bloodstream form mutant and the action of alpha-difluoromethylornithine.
    Li F; Hua SB; Wang CC; Gottesdiener KM
    Exp Parasitol; 1998 Mar; 88(3):255-7. PubMed ID: 9562432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further studies on difluoromethylornithine in African trypanosomes.
    McCann PP; Bacchi CJ; Clarkson AB; Seed JR; Nathan HC; Amole BO; Hutner SH; Sjoerdsma A
    Med Biol; 1981 Dec; 59(5-6):434-40. PubMed ID: 6175860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of DL-alpha-difluoromethylornithine against susceptible and drug-resistant Trypanosoma brucei brucei.
    Zweygarth E; Kaminsky R
    Acta Trop; 1991 Jan; 48(3):223-32. PubMed ID: 1671624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyamine metabolism: a potential therapeutic target in trypanosomes.
    Bacchi CJ; Nathan HC; Hutner SH; McCann PP; Sjoerdsma A
    Science; 1980 Oct; 210(4467):332-4. PubMed ID: 6775372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo trypanocidal activities of new S-adenosylmethionine decarboxylase inhibitors.
    Bacchi CJ; Brun R; Croft SL; Alicea K; Bühler Y
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1448-53. PubMed ID: 8726018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of polyamine biosynthesis by alpha-difluoromethylornithine in African trypanosomes and Pneumocystis carinii as a basis of chemotherapy: biochemical and clinical aspects.
    McCann PP; Bacchi CJ; Clarkson AB; Bey P; Sjoerdsma A; Schecter PJ; Walzer PD; Barlow JL
    Am J Trop Med Hyg; 1986 Nov; 35(6):1153-6. PubMed ID: 3098121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Front-line glioblastoma chemotherapeutic temozolomide is toxic to Trypanosoma brucei and potently enhances melarsoprol and eflornithine.
    Steverding D; Rushworth SA
    Exp Parasitol; 2017 Jul; 178():45-50. PubMed ID: 28552794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic activity of 5-substituted 2-nitroimidazoles (Ro 15-0216 and benznidazole) and DL-alpha-difluoromethylornithine on Trypanosoma brucei brucei.
    Zweygarth E; Kaminsky R; Sayer PD; van Nieuwenhove S
    Ann Soc Belg Med Trop; 1990 Dec; 70(4):269-79. PubMed ID: 2291692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catalytic irreversible inhibition of Trypanosoma brucei brucei ornithine decarboxylase by substrate and product analogs and their effects on murine trypanosomiasis.
    Bitonti AJ; Bacchi CJ; McCann PP; Sjoerdsma A
    Biochem Pharmacol; 1985 May; 34(10):1773-7. PubMed ID: 3924048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the ornithine decarboxylase inhibitors DL-alpha-difluoromethylornithine and alpha-monofluoromethyldehydroornithine methyl ester alone and in combination with suramin against Trypanosoma brucei brucei central nervous system models.
    Bacchi CJ; Nathan HC; Clarkson AB; Bienen EJ; Bitonti AJ; McCann PP; Sjoerdsma A
    Am J Trop Med Hyg; 1987 Jan; 36(1):46-52. PubMed ID: 3101528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo efficacies of 5'-methylthioadenosine analogs as trypanocides.
    Bacchi CJ; Sanabria K; Spiess AJ; Vargas M; Marasco CJ; Jimenez LM; Goldberg B; Sufrin JR
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2108-12. PubMed ID: 9333033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trypanosoma brucei CYP51: Essentiality and Targeting Therapy in an Experimental Model.
    Dauchy FA; Bonhivers M; Landrein N; Dacheux D; Courtois P; Lauruol F; Daulouède S; Vincendeau P; Robinson DR
    PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005125. PubMed ID: 27855164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cure of murine Trypanosoma brucei rhodesiense infections with an S-adenosylmethionine decarboxylase inhibitor.
    Bacchi CJ; Nathan HC; Yarlett N; Goldberg B; McCann PP; Bitonti AJ; Sjoerdsma A
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2736-40. PubMed ID: 1482141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of gambiense sleeping sickness in the Sudan with oral DFMO (DL-alpha-difluoromethylornithine), an inhibitor of ornithine decarboxylase; first field trial.
    Van Nieuwenhove S; Schechter PJ; Declercq J; Boné G; Burke J; Sjoerdsma A
    Trans R Soc Trop Med Hyg; 1985; 79(5):692-8. PubMed ID: 3938090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of combinations of difluoromethylornithine and bleomycin in a mouse model of central nervous system African trypanosomiasis.
    Clarkson AB; Bacchi CJ; Mellow GH; Nathan HC; McCann PP; Sjoerdsma A
    Proc Natl Acad Sci U S A; 1983 Sep; 80(18):5729-33. PubMed ID: 6193522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.